Roche, GSK cancer pill combos look similar in showdown
September 29, 2014 at 02:59 AM EDT
MADRID, Sept 29 (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline have yielded similar results in separate clinical trials, leaving doctors with little to choose between the two regimens.
